The global healthcare antimicrobial plastics market is expected to grow at a CAGR of 6.5% during the forecast period, to reach USD 3.2 billion by 2030. The growth of this market can be attributed to the increasing demand for antimicrobial plastics in hospitals and pharmacies, as well as in households and medical research facilities. Commodity plastic is expected to account for the largest share of the global healthcare antimicrobial plastics market during the forecast period, followed by engineering plastic and high performance plastic. Commodity plastic is used in various applications such as hospital equipment, household items, medical research equipment and pharmaceutical packaging materials due to its low cost and ease of availability. Engineering plastics are used in applications such as surgical instruments due to their durability against wear-and-tear conditions while high performance plastics are used in applications such as implants due to their ability to withstand harsh environments without degrading over time.
- The global healthcare antimicrobial plastics market is expected to grow at a CAGR of 6.5% from 2017 to 2025.
- The increasing demand for antimicrobial plastics in the healthcare sector is one of the major factors driving the growth of this market.
- Increasing awareness about the benefits of using antimicrobial plastics in hospitals and other medical facilities is also expected to fuel this market's growth over the next few years.
- In addition, rising investments in research and development activities related to these products are also anticipated to have a positive impact on their demand over time as they help manufacturers develop more efficient products with enhanced features and functionalities that can be used for various applications across different industries such as healthcare, food packaging, automotive industry etc, which will further boost their adoption rates globally .
Industry Growth Insights published a new data on “Healthcare Antimicrobial Plastics Market”. The research report is titled “Healthcare Antimicrobial Plastics Market research by Types (Commodity Plastic, Engineering Plastic, High Performance Plastic), By Applications (Hospital, Pharmacy, Household, Medical Research), By Players/Companies BASF SE (Germany), Bayer MaterialScience AG (Germany), The Dow Chemical Company (US), Clariant AG (Switzerland), Lonza Group AG (Switzerland), Microban International (US), Parx Plastic BV (The Netherlands), King Plastic Corporation (US), Biocote (UK), Milliken Chemical (US), Sanitized AG (Switzerland), PolyOne Corporation (US), Ticona Engineering Polymers (US), DSM (Netherlands), Doeflex-Vitapol (UK)”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Healthcare Antimicrobial Plastics Market Research Report
By Type
Commodity Plastic, Engineering Plastic, High Performance Plastic
By Application
Hospital, Pharmacy, Household, Medical Research
By Companies
BASF SE (Germany), Bayer MaterialScience AG (Germany), The Dow Chemical Company (US), Clariant AG (Switzerland), Lonza Group AG (Switzerland), Microban International (US), Parx Plastic BV (The Netherlands), King Plastic Corporation (US), Biocote (UK), Milliken Chemical (US), Sanitized AG (Switzerland), PolyOne Corporation (US), Ticona Engineering Polymers (US), DSM (Netherlands), Doeflex-Vitapol (UK)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Healthcare Antimicrobial Plastics Market Report Segments:
The global Healthcare Antimicrobial Plastics market is segmented on the basis of:
Types
Commodity Plastic, Engineering Plastic, High Performance Plastic
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Pharmacy, Household, Medical Research
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BASF SE (Germany)
- Bayer MaterialScience AG (Germany)
- The Dow Chemical Company (US)
- Clariant AG (Switzerland)
- Lonza Group AG (Switzerland)
- Microban International (US)
- Parx Plastic BV (The Netherlands)
- King Plastic Corporation (US)
- Biocote (UK)
- Milliken Chemical (US)
- Sanitized AG (Switzerland)
- PolyOne Corporation (US)
- Ticona Engineering Polymers (US)
- DSM (Netherlands)
- Doeflex-Vitapol (UK)
Highlights of The Healthcare Antimicrobial Plastics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Commodity Plastic
- Engineering Plastic
- High Performance Plastic
- By Application:
- Hospital
- Pharmacy
- Household
- Medical Research
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Healthcare Antimicrobial Plastics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Healthcare antimicrobial plastics are a type of plastic that is designed to resist the growth of bacteria and other microorganisms. Healthcare antimicrobial plastics are often used in medical devices, such as catheters and implants, to protect them from infection.
Some of the major players in the healthcare antimicrobial plastics market are BASF SE (Germany), Bayer MaterialScience AG (Germany), The Dow Chemical Company (US), Clariant AG (Switzerland), Lonza Group AG (Switzerland), Microban International (US), Parx Plastic BV (The Netherlands), King Plastic Corporation (US), Biocote (UK), Milliken Chemical (US), Sanitized AG (Switzerland), PolyOne Corporation (US), Ticona Engineering Polymers (US), DSM (Netherlands), Doeflex-Vitapol (UK).
The healthcare antimicrobial plastics market is expected to grow at a compound annual growth rate of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Healthcare Antimicrobial Plastics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Healthcare Antimicrobial Plastics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Healthcare Antimicrobial Plastics Market - Supply Chain
4.5. Global Healthcare Antimicrobial Plastics Market Forecast
4.5.1. Healthcare Antimicrobial Plastics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Healthcare Antimicrobial Plastics Market Size (000 Units) and Y-o-Y Growth
4.5.3. Healthcare Antimicrobial Plastics Market Absolute $ Opportunity
5. Global Healthcare Antimicrobial Plastics Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Healthcare Antimicrobial Plastics Market Size and Volume Forecast by Type
5.3.1. Commodity Plastic
5.3.2. Engineering Plastic
5.3.3. High Performance Plastic
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Healthcare Antimicrobial Plastics Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Healthcare Antimicrobial Plastics Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Pharmacy
6.3.3. Household
6.3.4. Medical Research
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Healthcare Antimicrobial Plastics Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Healthcare Antimicrobial Plastics Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Healthcare Antimicrobial Plastics Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Healthcare Antimicrobial Plastics Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Healthcare Antimicrobial Plastics Demand Share Forecast, 2019-2026
9. North America Healthcare Antimicrobial Plastics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Healthcare Antimicrobial Plastics Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Healthcare Antimicrobial Plastics Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Pharmacy
9.4.3. Household
9.4.4. Medical Research
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Healthcare Antimicrobial Plastics Market Size and Volume Forecast by Type
9.7.1. Commodity Plastic
9.7.2. Engineering Plastic
9.7.3. High Performance Plastic
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Healthcare Antimicrobial Plastics Demand Share Forecast, 2019-2026
10. Latin America Healthcare Antimicrobial Plastics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Healthcare Antimicrobial Plastics Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Healthcare Antimicrobial Plastics Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Pharmacy
10.4.3. Household
10.4.4. Medical Research
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Healthcare Antimicrobial Plastics Market Size and Volume Forecast by Type
10.7.1. Commodity Plastic
10.7.2. Engineering Plastic
10.7.3. High Performance Plastic
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Healthcare Antimicrobial Plastics Demand Share Forecast, 2019-2026
11. Europe Healthcare Antimicrobial Plastics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Healthcare Antimicrobial Plastics Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Healthcare Antimicrobial Plastics Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Pharmacy
11.4.3. Household
11.4.4. Medical Research
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Healthcare Antimicrobial Plastics Market Size and Volume Forecast by Type
11.7.1. Commodity Plastic
11.7.2. Engineering Plastic
11.7.3. High Performance Plastic
11.8. Basis Point Share (BPS) Anlysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Healthcare Antimicrobial Plastics Demand Share, 2019-2026
12. Asia Pacific Healthcare Antimicrobial Plastics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Healthcare Antimicrobial Plastics Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Healthcare Antimicrobial Plastics Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Pharmacy
12.4.3. Household
12.4.4. Medical Research
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Healthcare Antimicrobial Plastics Market Size and Volume Forecast by Type
12.7.1. Commodity Plastic
12.7.2. Engineering Plastic
12.7.3. High Performance Plastic
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Healthcare Antimicrobial Plastics Demand Share, 2019-2026
13. Middle East & Africa Healthcare Antimicrobial Plastics Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Healthcare Antimicrobial Plastics Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Healthcare Antimicrobial Plastics Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Pharmacy
13.4.3. Household
13.4.4. Medical Research
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Healthcare Antimicrobial Plastics Market Size and Volume Forecast by Type
13.7.1. Commodity Plastic
13.7.2. Engineering Plastic
13.7.3. High Performance Plastic
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Healthcare Antimicrobial Plastics Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Healthcare Antimicrobial Plastics Market: Market Share Analysis
14.2. Healthcare Antimicrobial Plastics Distributors and Customers
14.3. Healthcare Antimicrobial Plastics Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. BASF SE (Germany)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Bayer MaterialScience AG (Germany)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. The Dow Chemical Company (US)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Clariant AG (Switzerland)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Lonza Group AG (Switzerland)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Microban International (US)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Parx Plastic BV (The Netherlands)
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. King Plastic Corporation (US)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Biocote (UK)
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Milliken Chemical (US)
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Sanitized AG (Switzerland)
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. PolyOne Corporation (US)
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Ticona Engineering Polymers (US)
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. DSM (Netherlands)
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Doeflex-Vitapol (UK)
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook